Single blind randomized Phase III trial to investigate the benefit of a focal lesion ablative microboost in prostate cancer (FLAME-trial): study protocol for a randomized controlled trial

BACKGROUND: The treatment results of external beam radiotherapy for intermediate and high risk prostate cancer patients are insufficient with five-year biochemical relapse rates of approximately 35%. Several randomized trials have shown that dose escalation to the entire prostate improves biochemica...

Descripción completa

Detalles Bibliográficos
Autores principales: Lips, Irene M, van der Heide, Uulke A, Haustermans, Karin, van Lin, Emile NJT, Pos, Floris, Franken, Stefan PG, Kotte, Alexis NTJ, van Gils, Carla H, van Vulpen, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286435/
https://www.ncbi.nlm.nih.gov/pubmed/22141598
http://dx.doi.org/10.1186/1745-6215-12-255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3286435/
https://www.ncbi.nlm.nih.gov/pubmed/22141598
http://dx.doi.org/10.1186/1745-6215-12-255

Ejemplares similares